Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo.
about
Diarrheagenic Escherichia coli.Increased adherence and expression of virulence genes in a lineage of Escherichia coli O157:H7 commonly associated with human infections.Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent mannerThe role of lymphostatin/EHEC factor for adherence-1 in the pathogenesis of gram negative infectionRecent advances in understanding enteric pathogenic Escherichia coli.Citrobacter rodentium of mice and man.Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium.Identification of virulence genes linked with diarrhea due to atypical enteropathogenic Escherichia coli by DNA microarray analysis and PCR.Bacillus subtilis-mediated protection from Citrobacter rodentium-associated enteric disease requires espH and functional flagella.Mutational Analysis of the Chlamydia muridarum Plasticity ZoneQuantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens.Biophysical Characterization and Activity of Lymphostatin, a Multifunctional Virulence Factor of Attaching and Effacing Escherichia coli.Type 3 Muscarinic Receptors Contribute to Clearance of Citrobacter rodentium.Pathogenicity Island O-122 in enteropathogenic Escherichia coli strains is associated with diarrhea severity in children from Lima Peru.The bacterial virulence factor lymphostatin compromises intestinal epithelial barrier function by modulating rho GTPases.Protective and destructive innate immune responses to enteropathogenic Escherichia coli and related A/E pathogens.Decreased expression of colonic Slc26a3 and carbonic anhydrase iv as a cause of fatal infectious diarrhea in mice.LEEways: tales of EPEC, ATEC and EHEC.Microbes, intestinal inflammation and probiotics.In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections.Inhibition of Antigen-Specific and Nonspecific Stimulation of Bovine T and B Cells by Lymphostatin from Attaching and Effacing Escherichia coli.Protease-activated Receptor 1 Plays a Proinflammatory Role in Colitis by Promoting Th17-related Immunity.Prevalence and characteristics of the O122 pathogenicity island in typical and atypical enteropathogenic Escherichia coli strains.Distribution of pathogenicity islands OI-122, OI-43/48, and OI-57 and a high-pathogenicity island in Shiga toxin-producing Escherichia coli.Systematic identification and sequence analysis of the genomic islands of the enteropathogenic Escherichia coli strain B171-8 by the combined use of whole-genome PCR scanning and fosmid mapping.The Citrobacter rodentium genome sequence reveals convergent evolution with human pathogenic Escherichia coli.Attaching and effacing (A/E) lesion formation by enteropathogenic E. coli on human intestinal mucosa is dependent on non-LEE effectors.Direct manipulation of T lymphocytes by proteins of gastrointestinal bacterial pathogens.Chlamydia muridarum Genital and Gastrointestinal Infection Tropism is Mediated by Distinct Chromosomal Factors.
P2860
Q28078385-C70C3FFB-06EB-4A6C-A436-5EF17E4F64FAQ33389308-D4A075DD-73A7-4D9C-B839-13A0593A13A0Q33389633-D0A4A7BB-E803-41C9-B32A-D14FD2393CC4Q33398124-106BDF27-9529-4EAA-8E21-AB2D1D2692D3Q34375210-F7B6495C-CDA6-4F16-8EB6-A4AECDCDDAD9Q34470352-688369BF-63EF-44A9-A06F-8187BF12414BQ34492843-2876C98E-7F85-4F0F-A19D-3A31868F62C5Q35073619-BB91D05D-3081-46E1-8564-C0E2837A757BQ35689478-C6E7DEE7-0280-4430-86B8-520F966BE069Q35745572-3D3D33AA-6A45-45C0-BA2A-0D55CE66F453Q36211798-07BC8631-227F-459E-B051-25251230FE88Q36674689-C8BFCD1E-8BD0-4641-8211-62D5339D71BBQ36765812-03F5713B-588F-4871-AA4C-C6AFF7F09483Q36988186-11C5C49F-255F-4AAE-A882-41EBEED77111Q37164543-FF753FFB-AF57-4147-865F-81BD4C4E4939Q37174121-0E20DAE0-634E-4846-8DCD-235E081D591EQ37333481-EC20AA3A-BC87-478A-A64F-00F53CC082DDQ37780578-DDCD8BA5-DEA9-4E18-98C6-6CF17FBE1937Q37965684-5C5651D4-BBC6-4731-8276-BDF2536CB97FQ38086226-91FA6965-EF5A-4A5E-8BDF-F65442E33E0CQ38727509-CC1C4FE1-C7C7-4805-9214-846CFE2A51F5Q38906013-1BDE4C11-DC72-4A9F-A0BD-DBCC1A126898Q39900258-809100FB-D40D-4B5E-92B2-EE5DB72AB3FDQ40524748-5E49D401-B110-4115-BA93-43A8AF06CE3FQ42227031-07F47DA6-6246-4828-A089-A2D7C6C27B03Q42938903-1219C6F8-8529-4921-A3E5-DCB7757815C1Q47097262-FF608601-32AE-4BFF-900A-E91E8AFF88EAQ50020365-7AF7F01A-9E95-431E-9100-4F65E5614B00Q52691343-BEDF4881-6795-4361-A72C-8C1178E33985
P2860
Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Citrobacter rodentium lifA/efa ...... rypt cell hyperplasia in vivo.
@ast
Citrobacter rodentium lifA/efa ...... rypt cell hyperplasia in vivo.
@en
type
label
Citrobacter rodentium lifA/efa ...... rypt cell hyperplasia in vivo.
@ast
Citrobacter rodentium lifA/efa ...... rypt cell hyperplasia in vivo.
@en
prefLabel
Citrobacter rodentium lifA/efa ...... rypt cell hyperplasia in vivo.
@ast
Citrobacter rodentium lifA/efa ...... rypt cell hyperplasia in vivo.
@en
P2093
P2860
P1476
Citrobacter rodentium lifA/efa ...... rypt cell hyperplasia in vivo.
@en
P2093
Brian Babbin
Daniel Kalman
Ifor R Williams
Isabel C A Scaletsky
Jan-Michael A Klapproth
Maiko Sasaki
Melanie Sherman
Michael S Donnenberg
Paula J Fernandes
P2860
P304
P356
10.1128/IAI.73.3.1441-1451.2005
P407
P50
P577
2005-03-01T00:00:00Z